Metabolic disorders often overlap, making diabetes and endocrine connections a critical area of study. Hormonal imbalances involving the thyroid, adrenal, and pituitary glands influence glucose metabolism and insulin function. Conditions such as Cushing’s syndrome and hypothyroidism exacerbate insulin resistance, while polycystic ovary syndrome (PCOS) increases the risk of type 2 diabetes. Growth hormone and cortisol fluctuations also affect glycemic control, highlighting the need for a multidisciplinary approach in diagnosis and treatment. Advances in endocrinology have improved our understanding of these interactions, leading to targeted therapies that address both diabetes and underlying hormonal conditions. Recognizing these connections allows for more personalized and effective management strategies.
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
Belize Bible College, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States